The National Institutes of Health (NIH) is offering a federal grant opportunity titled "Integrating Biospecimen Science Approaches into Clinical Assay Development (U01 Clinical Trial Not Allowed)". This grant aims to support extramural research in investigating and mitigating challenges faced in clinical assay development and subsequent analytical validation due to preanalytical variability in tumor tissue biopsies, blood biospecimens utilized as liquid biopsies, or other biospecimens. The research funded under this grant will explore the preanalytical variability associated with the procurement and study of various biospecimens, such as small biopsies, blood, tissue swabs, tissue secretions, and bodily fluids. The goal is to improve the understanding of how different preanalytical conditions affect biomarkers and to expedite biomarker clinical assay development through evidence-based standardization of biopsy handling practices. The grant does not require cost sharing or matching and falls under the category of health. The deadline for application submission is September 13, 2024. For more information and to apply, visit the following link: Integrating Biospecimen Science Approaches into Clinical Assay Development Grant.